Announcements

  • Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?

    The AAPS Journal just shared this editorial from the AAPS Biomarker & Precision Medicine Community on the 2025 FDA BMVB Guidance with authors spanning 19 organizations.

    AAPS Communities unite members with a common interest in a specific topic in a web-based, always-available, virtual environment. Join us in giving a round of applause to these Community leaders. 👏 👏